INTELLIGENCE IN ACTION

Reinventing the Health IT Adoption Curve: Price Transparency at the Point of Care

November 14, 2018

Good news on the health IT front: The Surescripts Network Alliance™ is serving the needs of both providers and patients by delivering prescription price transparency and patient-specific benefit information at the point of care. This breakthrough technology is available now, and it’s catching on at an impressive rate.

Since its launch last year, there has been a 40-fold increase in the number of prescribers who have used Real-Time Prescription Benefit—a total of 30 million times—to view patient-specific prescription price information, plus therapeutic alternatives, within their electronic health record (EHR).

The solution’s rapid rate of growth is driven by collaboration across the network with several EHR software vendors and pharmacy benefit managers (PBMs) adopting or going live with Real-Time Prescription Benefit in recent months.  

EHRs representing 77 percent of U.S. prescribers have already signed on, including Allscripts, Aprima Medical Software, Cerner, eClinicalWorks, Epic, Modernizing Medicine and NextGen Healthcare.

Real-Time Prescription Benefit provides patient benefit data directly from leading PBMs and health plans, including CVS Health, DST, which was acquired by SS&C Technologies, Express Scripts and Navitus, who collectively reach 70 percent of U.S. covered lives.

It’s simple: Easing the way for patients to pick up and begin their medications makes them more likely to adhere to their treatment plans. And improved medication adherence improves the quality, safety and cost of healthcare across the board.

Watch the video below to see how Real-Time Prescription Benefit is a breakthrough technology that solves a major healthcare challenge.


Read the latest press release to learn more about how Surescripts is improving the prescribing experience for thousands of providers and patients across the country.

Related Articles

May 21, 2019

An Urgent Call for Transformation: Prescribers Need Better Information and a Streamlined Specialty Prescribing Process

Most likely, you or someone you love has been impacted by a complex or chronic illness like cancer or multiple sclerosis. Sadly, these diseases—and the cost of medications to treat them—are on the rise. More than half of specialty drugs cost in excess of $100,000 a year. As a result, spending on branded specialty medications is rising by 10 percent a year and is projected to surpass half of all medication spending by 2022, even though these drugs comprise just a fraction of all prescribed medications.

Read more...
May 20, 2019

Federal Government Issues Final Rule: Part D Plans Must Adopt a Real Time Benefit Tool

On May 16, the Centers for Medicare and Medicaid Services (CMS) issued its final rule: Medicare Advantage and Part D Drug Pricing Final Rule (CMS-4180-F).

We’ve been closely following this proposal as it relates to e-prescribing and the Part D prescription drug plan in particular. The rule is designed to accelerate the use of Real Time Benefit Tools (RTBTs), such as Surescripts Real-Time Prescription Benefit.

Read more...
April 15, 2019

Older, Sicker Patients Will Benefit from Real-Time Benefit Tools, So Let’s Not Delay Using Them.

Healthcare costs are increasingly prohibitive for too many Americans, and these costs can hit older Americans especially hard. That’s why we applaud the Centers for Medicare & Medicaid Services (CMS) proposed rule on real-time benefit tools (RTBT). Read more...

INTELLIGENCE IN ACTION, DELIVERED TO YOUR INBOX